BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22703238)

  • 1. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
    Breyer MK; Rutten EP; Locantore NW; Watkins ML; Miller BE; Wouters EF;
    Eur J Clin Invest; 2012 Sep; 42(9):983-91. PubMed ID: 22703238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin.
    Breyer MK; Rutten EP; Vernooy JH; Spruit MA; Dentener MA; van der Kallen C; vanGreevenbroek MM; Wouters EF
    Respir Med; 2011 Jul; 105(7):1046-53. PubMed ID: 21367591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
    Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
    Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
    Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
    Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local inflammation occurs before systemic inflammation in patients with COPD.
    He Z; Chen Y; Chen P; Wu G; Cai S
    Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between BODE index and systemic inflammatory biomarkers in COPD.
    Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
    COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
    Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
    Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating visfatin in chronic obstructive pulmonary disease.
    Liu X; Ji Y; Chen J; Li S; Luo F
    Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between physical capacity, nutritional status and systemic inflammation in COPD.
    Hallin R; Janson C; Arnardottir RH; Olsson R; Emtner M; Branth S; Boman G; Slinde F
    Clin Respir J; 2011 Jul; 5(3):136-42. PubMed ID: 21679348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.
    Uzum AK; Aydin MM; Tutuncu Y; Omer B; Kiyan E; Alagol F
    Eur J Intern Med; 2014 Apr; 25(4):364-9. PubMed ID: 23523152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
    Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study.
    Boutou AK; Pitsiou GG; Stanopoulos I; Kontakiotis T; Kyriazis G; Argyropoulou P
    QJM; 2012 Jul; 105(7):657-63. PubMed ID: 22355163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum adiponectin level in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Tasaka S; Hasegawa N; Nishimura T; Yamasawa W; Kamata H; Shinoda H; Kimizuka Y; Fujiwara H; Hirose H; Ishizaka A
    Respiration; 2010; 79(5):383-7. PubMed ID: 19641295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis.
    Kontunen P; Vuolteenaho K; Nieminen R; Lehtimäki L; Kautiainen H; Kesäniemi Y; Ukkola O; Kauppi M; Hakala M; Moilanen E
    Scand J Rheumatol; 2011; 40(4):256-62. PubMed ID: 21453187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition and plasma levels of inflammatory biomarkers in COPD.
    Eagan TM; Aukrust P; Ueland T; Hardie JA; Johannessen A; Mollnes TE; Damås JK; Bakke PS; Wagner PD
    Eur Respir J; 2010 Nov; 36(5):1027-33. PubMed ID: 20413541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
    Komnata K
    Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.